Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma

被引：0
|
作者：
C. Shu
Q. Wang
X. Yan
J. Wang
机构：
[1] Nankai University,School of Medicine
[2] Tianjin Huan Hu Hospital,Tianjin Cerebral Vascular and Neural Degenerative Disease Key Laboratory, Tianjin Neurosurgery Institute
来源：
Clinical and Translational Oncology | 2018年 / 20卷
关键词：
Pediatric ependymoma; CD44; Survival; miRNA; Prognostic biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1439 / 1447
页数：8
相关论文
共 50 条
  • [41] Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
    Xintao Li
    Xin Ma
    Luyao Chen
    Liangyou Gu
    Yu Zhang
    Fan Zhang
    Yun Ouyang
    Yu Gao
    Qingbo Huang
    Xu Zhang
    Scientific Reports, 5
  • [42] Expression of CD44 and the survival in glioma: a meta-analysis
    Wu, Gang
    Song, Xinghui
    Liu, Jun
    Li, Shize
    Gao, Weiqin
    Qiu, Mingxing
    Yang, Changjin
    Ma, Yiming
    Chen, Yuhong
    BIOSCIENCE REPORTS, 2020, 40
  • [43] Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
    Li, Xintao
    Ma, Xin
    Chen, Luyao
    Gu, Liangyou
    Zhang, Yu
    Zhang, Fan
    Ouyang, Yun
    Gao, Yu
    Huang, Qingbo
    Zhang, Xu
    SCIENTIFIC REPORTS, 2015, 5
  • [44] TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma
    Pierscianek, Daniela
    Teuber-Hanselmann, Sarah
    Ahmadipour, Yahya
    Oppong, Marvin Darkwah
    Unteroberdoerster, Meike
    Mueller, Oliver
    Jabbarli, Ramazan
    Sure, Ulrich
    Zhu, Yuan
    El Hindy, Nicolai
    NEUROPATHOLOGY, 2020, 40 (02) : 138 - 143
  • [45] MRI-based texture analysis for differentiate between pediatric posterior fossa ependymoma type A and B
    Cui, Zhimeng
    Ren, Gang
    Cai, Rong
    Wu, Chenqing
    Shi, HaoTing
    Wang, Xinyun
    Zhu, Mingjie
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 152
  • [46] High Level of CD44 Expression and Soluble CD44 Secretion Mediate Trastuzumab Resistance in HER2 Positive Breast Cancer.
    Jin, Q.
    Baek, J. M.
    Boulbes, D. R.
    Esteva, F. J.
    CANCER RESEARCH, 2011, 71
  • [47] Prognostic value of CD44 expression in patient with Borrmann type 4 gastric carcinoma
    Miyazaki, N
    Ishikawa, K
    Katsuta, T
    Shiraishi, N
    Adachi, Y
    Kitano, S
    GASTROENTEROLOGY, 1997, 112 (04) : A616 - A616
  • [48] Intense CD44 Expression Is a Negative Prognostic Factor in Tonsillar and Base of Tongue Cancer
    Lindquist, David
    Ahrlund-Richter, Andreas
    Tarjan, Miklos
    Tot, Tibor
    Dalianis, Tina
    ANTICANCER RESEARCH, 2012, 32 (01) : 153 - 161
  • [49] CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection
    Morine, Yuji
    Imura, Satoru
    Ikemoto, Tetsuya
    Iwahashi, Shuichi
    Saito, Yu
    Shimada, Mitsuo
    ANTICANCER RESEARCH, 2017, 37 (10) : 5701 - 5705
  • [50] Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance
    Ghaffarzadehgan, Kamran
    Jafarzadeh, Mostafa
    Raziee, Hamid Reza
    Sima, Hamid Reza
    Esmaili-Shandiz, Ehsan
    Hosseinnezhad, Hanieh
    Taghizadeh-Kermani, Ali
    Moaven, Omeed
    Bahrani, Maryam
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (41) : 6376 - 6381
12345